Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 18283712)

1.

Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

Knitlova J, Hajkova V, Voska L, Elsterova J, Obrova B, Melkova Z.

PLoS One. 2014 Dec 8;9(12):e114374. doi: 10.1371/journal.pone.0114374. eCollection 2014.

2.

OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Goulding J, Tahiliani V, Salek-Ardakani S.

Immunol Rev. 2011 Nov;244(1):149-68. doi: 10.1111/j.1600-065X.2011.01062.x. Review.

3.

Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Zhao Y, Adams YF, Croft M.

Viral Immunol. 2011 Oct;24(5):387-96. doi: 10.1089/vim.2011.0020. Epub 2011 Sep 29.

4.

Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.

Salek-Ardakani S, Moutaftsi M, Sette A, Croft M.

J Virol. 2011 Sep;85(17):9051-9. doi: 10.1128/JVI.00619-11. Epub 2011 Jun 29.

5.

Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Rehm KE, Roper RL.

Vaccine. 2011 Apr 12;29(17):3276-83. doi: 10.1016/j.vaccine.2011.02.023. Epub 2011 Feb 23.

6.

Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development.

Kovjazin R, Volovitz I, Daon Y, Vider-Shalit T, Azran R, Tsaban L, Carmon L, Louzoun Y.

Mol Immunol. 2011 Apr;48(8):1009-18. doi: 10.1016/j.molimm.2011.01.006. Epub 2011 Feb 12.

7.

Smallpox vaccines: targets of protective immunity.

Moss B.

Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Review.

8.

Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.

Green S, Ennis FA, Mathew A.

Vaccine. 2011 Feb 11;29(8):1666-76. doi: 10.1016/j.vaccine.2010.12.036. Epub 2010 Dec 31.

9.

The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.

Salek-Ardakani S, Flynn R, Arens R, Yagita H, Smith GL, Borst J, Schoenberger SP, Croft M.

J Clin Invest. 2011 Jan;121(1):296-307. doi: 10.1172/JCI42056. Epub 2010 Dec 22.

10.

Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.

Hirao LA, Draghia-Akli R, Prigge JT, Yang M, Satishchandran A, Wu L, Hammarlund E, Khan AS, Babas T, Rhodes L, Silvera P, Slifka M, Sardesai NY, Weiner DB.

J Infect Dis. 2011 Jan 1;203(1):95-102. doi: 10.1093/infdis/jiq017.

11.

The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Kennedy RB, Poland GA.

Virology. 2010 Dec 20;408(2):232-40. doi: 10.1016/j.virol.2010.09.013. Epub 2010 Oct 18.

12.

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24.

13.
14.

Killing a killer: what next for smallpox?

McFadden G.

PLoS Pathog. 2010 Jan 29;6(1):e1000727. doi: 10.1371/journal.ppat.1000727. Review. No abstract available.

15.

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice.

Grosenbach DW, Berhanu A, King DS, Mosier S, Jones KF, Jordan RA, Bolken TC, Hruby DE.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):838-43. doi: 10.1073/pnas.0912134107. Epub 2009 Dec 22.

16.

Technical transformation of biodefense vaccines.

Lu S, Wang S.

Vaccine. 2009 Nov 5;27 Suppl 4:D8-D15. doi: 10.1016/j.vaccine.2009.08.055. Review.

17.

Vaccinia virus vaccines: past, present and future.

Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR.

Antiviral Res. 2009 Oct;84(1):1-13. doi: 10.1016/j.antiviral.2009.06.006. Epub 2009 Jun 26. Review.

18.

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.

Delaloye J, Roger T, Steiner-Tardivel QG, Le Roy D, Knaup Reymond M, Akira S, Petrilli V, Gomez CE, Perdiguero B, Tschopp J, Pantaleo G, Esteban M, Calandra T.

PLoS Pathog. 2009 Jun;5(6):e1000480. doi: 10.1371/journal.ppat.1000480. Epub 2009 Jun 19.

19.

The immunology of smallpox vaccines.

Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA.

Curr Opin Immunol. 2009 Jun;21(3):314-20. doi: 10.1016/j.coi.2009.04.004. Epub 2009 Jun 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk